. Author manuscript; available in PMC: 2014 Oct 20.

Published in final edited form as: Hepatology. 2010 Apr;51(4):1168–1175. doi: 10.1002/hep.23477

Table 3. KIR and HLA-C Associations in the Exposed Seronegative Aviremic Individuals.

Characteristic	Seronegative Aviremic n (%)	Chronic n (%)	P Value (Pc)	OR (95% CI)
Number of patients	48	257
KIR2DL2	22 (45.8)	136 (52.9)	036
KIR2DL3	43 (89.6)	223 (86.8)	0.59
Group 1 HLA-C	40 (83.3)	214 (83.3)	0.99
Group 2 HLA-C	28 (58.3)	181 (70.4)	0.10	0.59 (0.30-1.16)
KIR2DL2-C1	18 (37.5)	114 (44.4)	0.38
KIR2DL3-C1	36 (77.0)	187 (72.8)	0.75
KIR2DL3-C1 homozygous	12 (25.0)	25 (9.7)	0.003 (0.02)	3.1 (1.3-7.1)
KIR2DL3-C1 heterozygous	24 (50.0)	162 (63.0)	0.09	0.59 (0.30-1.14)